Spine
Stryker pulls spinal devices off the shelves following failure reports
MassDevice.com Q&A: K2M co-founder & CEO Eric Major
Revenues in the spine industry have been flat for several years now, with the largest players in the space reporting declines or low-single-digit growth.
Zimmer hammers out a deal with SpineCraft for its Apex device
Long-awaited ruling in Medtronic Infuse lawsuit could have ripple effect on industry
Federal pre-emption statutes have thus far stalled personal injury complaints over Medtronic’s (NYSE:MDT) troubled Infuse bone-growth protein, but new lawsuits may find their way to trial by claiming that the medtech titan is liable for injuries because it engaged in off-label marketing.
Baxano Surgical pays $6M to settle federal healthcare fraud beef
Can 2nd-tier spinal companies grow in a challenging sector?
Stephen Simpson